Related Experiment Video
Updated: Aug 8, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
LR1 regulates c-myc transcription in B-cell lymphomas
1Department of Molecular Biophysics and Biochemistry, Yale Medical School, New Haven, CT 06510.
Insights
LR1 protein acts as a transcription factor, activating the c-myc gene in specific B lymphocytes. This discovery suggests LR1 may also influence c-myc translocations in lymphoma.
Area of Science:
- Molecular Biology
- Gene Regulation
- Cancer Biology
Background:
- LR1 (106-kDa) is a DNA-binding protein initially linked to immunoglobulin class switch recombination in B lymphocytes.
- The c-myc oncogene is crucial in cell proliferation and is frequently dysregulated in cancers like Burkitt lymphoma.
Purpose of the Study:
- To investigate the role of LR1 in regulating the human c-myc gene.
- To determine if LR1 functions as a transcription factor for c-myc.
- To explore the potential dual role of LR1 in c-myc regulation and translocation.
Main Methods:
- Site-directed mutagenesis of the LR1 binding site upstream of the c-myc P1 promoter.
- Reporter gene assays in Burkitt lymphoma cell lines (Raji and BJAB).
- Bioinformatic analysis to identify LR1 recognition sites in immunoglobulin and c-myc loci.
Main Results:
- LR1 binds to a DNA site located 310 nucleotides upstream of the human c-myc P1 promoter.
- Mutation of this LR1 binding site significantly reduced reporter gene expression by 5.5-fold in Raji cells and 3.8-fold in BJAB cells.
- Multiple LR1 recognition consensus sequences were found at the immunoglobulin heavy-chain locus and the c-myc gene.
Conclusions:
- LR1 functions as a cell type-specific transcription factor that activates human c-myc expression.
- The presence of LR1 binding sites in both immunoglobulin and c-myc loci suggests a potential dual role in facilitating c-myc translocations and regulating its transcription.
- LR1 is implicated in the molecular mechanisms underlying B cell lymphomas.
Abstract:
LR1 is a 106-kDa sequence-specific DNA-binding protein first identified as a potential regulator of immunoglobulin class switch recombination in B lymphocytes. Here we report that LR1 binds to a site 310 nt upstream of the human c-myc P1 promoter. Mutation of this site decreases reporter gene expression 5.5-fold in the Burkitt lymphoma line Raji and 3.8-fold in the lymphoma line BJAB. These experiments show that LR1 can function as a transcription factor and identify it as a cell type-specific activator of c-myc expression. There are multiple matches to the LR1 recognition consensus at the immunoglobulin heavy-chain locus and at c-myc, which further suggests that LR1 may play a dual role, facilitating c-myc translocation as well as regulating c-myc transcription.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Master Transcription Regulators
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Intrinsic Apoptotic Pathway
Induced Pluripotent Stem Cells
Somatic cells are...

